Cargando…

Chlorhexidine for facility-based umbilical cord care: EN-BIRTH multi-country validation study

BACKGROUND: Umbilical cord hygiene prevents sepsis, a leading cause of neonatal mortality. The World Health Organization recommends 7.1% chlorhexidine digluconate (CHX) application to the umbilicus after home birth in high mortality contexts. In Bangladesh and Nepal, national policies recommend CHX...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaman, Sojib Bin, Siddique, Abu Bakkar, Ruysen, Harriet, KC, Ashish, Peven, Kimberly, Ameen, Shafiqul, Thakur, Nishant, Rahman, Qazi Sadeq-ur, Salim, Nahya, Gurung, Rejina, Tahsina, Tazeen, Rahman, Ahmed Ehsanur, Coffey, Patricia S., Rawlins, Barbara, Day, Louise T., Lawn, Joy E., Arifeen, Shams El
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995704/
https://www.ncbi.nlm.nih.gov/pubmed/33765947
http://dx.doi.org/10.1186/s12884-020-03338-4
_version_ 1783669965300170752
author Zaman, Sojib Bin
Siddique, Abu Bakkar
Ruysen, Harriet
KC, Ashish
Peven, Kimberly
Ameen, Shafiqul
Thakur, Nishant
Rahman, Qazi Sadeq-ur
Salim, Nahya
Gurung, Rejina
Tahsina, Tazeen
Rahman, Ahmed Ehsanur
Coffey, Patricia S.
Rawlins, Barbara
Day, Louise T.
Lawn, Joy E.
Arifeen, Shams El
author_facet Zaman, Sojib Bin
Siddique, Abu Bakkar
Ruysen, Harriet
KC, Ashish
Peven, Kimberly
Ameen, Shafiqul
Thakur, Nishant
Rahman, Qazi Sadeq-ur
Salim, Nahya
Gurung, Rejina
Tahsina, Tazeen
Rahman, Ahmed Ehsanur
Coffey, Patricia S.
Rawlins, Barbara
Day, Louise T.
Lawn, Joy E.
Arifeen, Shams El
author_sort Zaman, Sojib Bin
collection PubMed
description BACKGROUND: Umbilical cord hygiene prevents sepsis, a leading cause of neonatal mortality. The World Health Organization recommends 7.1% chlorhexidine digluconate (CHX) application to the umbilicus after home birth in high mortality contexts. In Bangladesh and Nepal, national policies recommend CHX use for all facility births. Population-based household surveys include optional questions on CHX use, but indicator validation studies are lacking. The Every Newborn Birth Indicators Research Tracking in Hospitals (EN-BIRTH) was an observational study assessing measurement validity for maternal and newborn indicators. This paper reports results regarding CHX. METHODS: The EN-BIRTH study (July 2017–July 2018) included three public hospitals in Bangladesh and Nepal where CHX cord application is routine. Clinical-observers collected tablet-based, time-stamped data regarding cord care during admission to labour and delivery wards as the gold standard to assess accuracy of women’s report at exit survey, and of routine-register data. We calculated validity ratios and individual-level validation metrics; analysed coverage, quality and measurement gaps. We conducted qualitative interviews to assess barriers and enablers to routine register-recording. RESULTS: Umbilical cord care was observed for 12,379 live births. Observer-assessed CHX coverage was very high at 89.3–99.4% in all 3 hospitals, although slightly lower after caesarean births in Azimpur (86.8%), Bangladesh. Exit survey-reported coverage (0.4–45.9%) underestimated the observed coverage with substantial “don’t know” responses (55.5–79.4%). Survey-reported validity ratios were all poor (0.01 to 0.38). Register-recorded coverage in the specific column in Bangladesh was underestimated by 0.2% in Kushtia but overestimated by 9.0% in Azimpur. Register-recorded validity ratios were good (0.9 to 1.1) in Bangladesh, and poor (0.8) in Nepal. The non-specific register column in Pokhara, Nepal substantially underestimated coverage (20.7%). CONCLUSIONS: Exit survey-report highly underestimated observed CHX coverage in all three hospitals. Routine register-recorded coverage was closer to observer-assessed coverage than survey reports in all hospitals, including for caesarean births, and was more accurately captured in hospitals with a specific register column. Inclusion of CHX cord care into registers, and tallied into health management information system platforms, is justified in countries with national policies for facility-based use, but requires implementation research to assess register design and data flow within health information systems. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-020-03338-4.
format Online
Article
Text
id pubmed-7995704
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79957042021-03-26 Chlorhexidine for facility-based umbilical cord care: EN-BIRTH multi-country validation study Zaman, Sojib Bin Siddique, Abu Bakkar Ruysen, Harriet KC, Ashish Peven, Kimberly Ameen, Shafiqul Thakur, Nishant Rahman, Qazi Sadeq-ur Salim, Nahya Gurung, Rejina Tahsina, Tazeen Rahman, Ahmed Ehsanur Coffey, Patricia S. Rawlins, Barbara Day, Louise T. Lawn, Joy E. Arifeen, Shams El BMC Pregnancy Childbirth Research BACKGROUND: Umbilical cord hygiene prevents sepsis, a leading cause of neonatal mortality. The World Health Organization recommends 7.1% chlorhexidine digluconate (CHX) application to the umbilicus after home birth in high mortality contexts. In Bangladesh and Nepal, national policies recommend CHX use for all facility births. Population-based household surveys include optional questions on CHX use, but indicator validation studies are lacking. The Every Newborn Birth Indicators Research Tracking in Hospitals (EN-BIRTH) was an observational study assessing measurement validity for maternal and newborn indicators. This paper reports results regarding CHX. METHODS: The EN-BIRTH study (July 2017–July 2018) included three public hospitals in Bangladesh and Nepal where CHX cord application is routine. Clinical-observers collected tablet-based, time-stamped data regarding cord care during admission to labour and delivery wards as the gold standard to assess accuracy of women’s report at exit survey, and of routine-register data. We calculated validity ratios and individual-level validation metrics; analysed coverage, quality and measurement gaps. We conducted qualitative interviews to assess barriers and enablers to routine register-recording. RESULTS: Umbilical cord care was observed for 12,379 live births. Observer-assessed CHX coverage was very high at 89.3–99.4% in all 3 hospitals, although slightly lower after caesarean births in Azimpur (86.8%), Bangladesh. Exit survey-reported coverage (0.4–45.9%) underestimated the observed coverage with substantial “don’t know” responses (55.5–79.4%). Survey-reported validity ratios were all poor (0.01 to 0.38). Register-recorded coverage in the specific column in Bangladesh was underestimated by 0.2% in Kushtia but overestimated by 9.0% in Azimpur. Register-recorded validity ratios were good (0.9 to 1.1) in Bangladesh, and poor (0.8) in Nepal. The non-specific register column in Pokhara, Nepal substantially underestimated coverage (20.7%). CONCLUSIONS: Exit survey-report highly underestimated observed CHX coverage in all three hospitals. Routine register-recorded coverage was closer to observer-assessed coverage than survey reports in all hospitals, including for caesarean births, and was more accurately captured in hospitals with a specific register column. Inclusion of CHX cord care into registers, and tallied into health management information system platforms, is justified in countries with national policies for facility-based use, but requires implementation research to assess register design and data flow within health information systems. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-020-03338-4. BioMed Central 2021-03-26 /pmc/articles/PMC7995704/ /pubmed/33765947 http://dx.doi.org/10.1186/s12884-020-03338-4 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zaman, Sojib Bin
Siddique, Abu Bakkar
Ruysen, Harriet
KC, Ashish
Peven, Kimberly
Ameen, Shafiqul
Thakur, Nishant
Rahman, Qazi Sadeq-ur
Salim, Nahya
Gurung, Rejina
Tahsina, Tazeen
Rahman, Ahmed Ehsanur
Coffey, Patricia S.
Rawlins, Barbara
Day, Louise T.
Lawn, Joy E.
Arifeen, Shams El
Chlorhexidine for facility-based umbilical cord care: EN-BIRTH multi-country validation study
title Chlorhexidine for facility-based umbilical cord care: EN-BIRTH multi-country validation study
title_full Chlorhexidine for facility-based umbilical cord care: EN-BIRTH multi-country validation study
title_fullStr Chlorhexidine for facility-based umbilical cord care: EN-BIRTH multi-country validation study
title_full_unstemmed Chlorhexidine for facility-based umbilical cord care: EN-BIRTH multi-country validation study
title_short Chlorhexidine for facility-based umbilical cord care: EN-BIRTH multi-country validation study
title_sort chlorhexidine for facility-based umbilical cord care: en-birth multi-country validation study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995704/
https://www.ncbi.nlm.nih.gov/pubmed/33765947
http://dx.doi.org/10.1186/s12884-020-03338-4
work_keys_str_mv AT zamansojibbin chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT siddiqueabubakkar chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT ruysenharriet chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT kcashish chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT pevenkimberly chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT ameenshafiqul chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT thakurnishant chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT rahmanqazisadequr chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT salimnahya chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT gurungrejina chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT tahsinatazeen chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT rahmanahmedehsanur chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT coffeypatricias chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT rawlinsbarbara chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT daylouiset chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT lawnjoye chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT arifeenshamsel chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy
AT chlorhexidineforfacilitybasedumbilicalcordcareenbirthmulticountryvalidationstudy